Affinage · Plasmodium

CLAG9

PF3D7_0935800 · cytoadherence linked asexual protein 9

Annotated
2026-09-08
14 papers in source corpus 10 papers cited in narrative 10 extracted findings

Mechanistic narrative

Synthesis pass · prose summary of the discoveries below

CLAG9 (PF3D7_0935800) is a ~220 kDa Plasmodium falciparum rhoptry protein that couples merozoite invasion machinery to the cytoadherence properties of the infected erythrocyte (PMID:10737759, PMID:15049814). It localizes to the basal bulb of merozoite rhoptries and is a component of the high-molecular-mass RhopH complex, co-purifying with RhopH2 and, in later work, with RAP1, RAP2, RAP3, and RhopH3 at the apical end of merozoites (PMID:15049814, PMID:31712270); individual complexes carry only one RhopH1/Clag product, so CLAG9-containing complexes are compositionally distinct from those bearing Clag2 or Clag3.1 (PMID:15953647). Functionally, targeted gene disruption and independent antisense inhibition both ablate cytoadherence of parasitized erythrocytes to CD36, establishing CLAG9 as essential for CD36-dependent binding (PMID:10737759, PMID:10989143). After invasion the complex is transferred to ring-stage parasites and CLAG9 traffics to the host erythrocyte membrane, where it exists in alkaline-extractable soluble and membrane-integral forms and, unlike CLAG3, presents a protease-resistant surface-exposed region (PMID:15049814, PMID:38930554). At the erythrocyte surface CLAG9 interacts with VAR2CSA and is required for trafficking of this PfEMP1 family member to the infected-cell surface (PMID:20823248). The CLAG9-RhopH complex also mediates merozoite binding to erythrocytes via the glycophorin A–band 3 receptor complex (PMID:31712270). CLAG9 knockout parasites grow normally in physiological medium, distinguishing CLAG9 from the growth-essential CLAG3 (PMID:38930554). In P. berghei, CLAG9 occupies a phylogenetic clade separate from CLAGX and cannot complement CLAGX (the functional clag3 ortholog) function (PMID:39894870).

Mechanistic history

Synthesis pass · year-by-year structured walk · 9 steps
  1. 2000 High

    Whether CLAG9 has a defined role in the pathogenic adhesion of infected erythrocytes was unknown; genetic loss-of-function established it as essential for cytoadherence to CD36.

    Evidence Targeted gene disruption and antisense RNA inhibition in P. falciparum with cytoadherence assays to CD36/C32 melanoma cells, plus plasmid reversion control

    PMID:10737759 PMID:10989143

    Open questions at the time
    • Did not identify the molecular basis linking a rhoptry protein to surface adhesion
    • No direct demonstration that CLAG9 itself contacts CD36
  2. 2004 High

    The subcellular identity of CLAG9 was undefined; multi-method imaging and complex purification placed it in the RhopH complex at the rhoptry basal bulb and showed transfer to ring stages after invasion.

    Evidence Immunofluorescence, immunoelectron microscopy, mass spectrometry, and co-immunoprecipitation with anti-RhopH2 in P. falciparum

    PMID:15049814

    Open questions at the time
    • Did not resolve how a rhoptry/RhopH protein produces the surface cytoadherence phenotype
    • Complex stoichiometry not defined
  3. 2005 Medium

    Whether CLAG9 shares complexes with other Clag paralogs was unresolved; co-IP showed CLAG9 complexes exclude Clag2 and Clag3.1, indicating one RhopH1/Clag product per complex.

    Evidence Anti-CLAG9 immunoprecipitation followed by Western blot for Clag2 and Clag3.1 in P. falciparum HB3 and 3D7

    PMID:15953647

    Open questions at the time
    • Single negative co-IP result
    • Does not establish functional consequence of compositional exclusivity
  4. 2010 Medium

    The mechanism linking CLAG9 to surface adhesion was unknown; CLAG9 was shown to interact with VAR2CSA and to be required for PfEMP1 trafficking to the infected-cell surface, and to be partly surface-exposed.

    Evidence Co-immunoprecipitation, immunofluorescence, trypsin sensitivity, and CLAG9-knockout analysis in P. falciparum

    PMID:20823248

    Open questions at the time
    • Single-lab co-IP without reciprocal validation of the CLAG9–VAR2CSA interaction
    • Molecular route by which a rhoptry protein directs PfEMP1 surface delivery not defined
  5. 2010 Medium

    Whether CLAG9 sequence contains discrete erythrocyte-binding determinants was untested; overlapping synthetic peptides identified high-affinity erythrocyte-binding regions that inhibited invasion.

    Evidence Receptor-ligand binding with synthetic peptides spanning CLAG9, RBC enzyme pre-treatment, and invasion inhibition assays

    PMID:20085836

    Open questions at the time
    • No genetic validation that these peptides map to functional binding regions in native CLAG9
    • Erythrocyte receptors identified only by apparent molecular mass
  6. 2020 Medium

    The full composition of the CLAG9 complex and its erythrocyte receptor were incompletely defined; MS and interaction assays placed CLAG9 with RAP1/2/3 and RhopH2/3 and linked complex binding to the glycophorin A–band 3 receptor.

    Evidence Immunoprecipitation-mass spectrometry, recombinant CLAG9 domain interaction assays, immunofluorescence, and erythrocyte binding assays in P. falciparum

    PMID:31712270

    Open questions at the time
    • Single-lab characterization
    • Direct affinity of native CLAG9 for glycophorin A/band 3 not quantified
  7. 2024 High

    How CLAG9 is partitioned at the host membrane and whether it is growth-essential was unclear; fractionation, protease treatment, and CRISPR knockout showed soluble and membrane-integral forms, a protease-resistant surface region distinct from CLAG3, and normal growth of CLAG9 knockouts.

    Evidence Epitope-tagging and co-localization, alkaline extraction, extracellular protease treatment, CRISPR/Cas9 knockout, growth and PSAC transport assays in P. falciparum

    PMID:38930554

    Open questions at the time
    • Membrane insertion mechanism not defined
    • Functional role of the two biochemical forms not resolved
  8. 2025 Medium

    Whether P. falciparum CLAG9 is functionally equivalent to CLAG3/CLAGX orthologs was untested; allelic replacement in P. berghei showed CLAG9 and CLAGX are distinct, non-complementary clades.

    Evidence Allelic replacement, inducible knockout, and guanidinium chloride haemolysis NPP assay in P. berghei

    PMID:39894870

    Open questions at the time
    • Does not define the endogenous function of P. berghei CLAG9 itself
    • Cross-species inference to P. falciparum CLAG9 role is indirect
  9. 2025 Medium

    New interactors of the CLAG9-containing complex were sought; the ankyrin-repeat protein PfANK_1 was shown to bind components of the PfClag9-RhopH complex with a defined interface.

    Evidence Co-immunoprecipitation, bio-layer interferometry, co-localization, molecular dynamics, and crystal structure of PfANK_1 in P. falciparum

    PMID:40614121

    Open questions at the time
    • Interaction mapped to the complex rather than confirmed as direct CLAG9–PfANK_1 contact
    • Functional consequence of the interaction not established

Open questions

Synthesis pass · forward-looking unresolved questions
  • The mechanistic chain by which a rhoptry RhopH-complex protein is exported to the erythrocyte membrane, inserts, and directs both CD36-dependent cytoadherence and PfEMP1 surface trafficking remains unresolved.
  • No structural model of membrane-integral CLAG9 at the host surface
  • How CLAG9 mechanistically couples RhopH-complex function to PfEMP1 trafficking is unknown
  • Direct receptor-binding footprint of native CLAG9 not defined

Mechanism profile

Synthesis pass · controlled-vocabulary classification
Partners
PFANK_1 (INTERACTS WITH THE CLAG9-RHOPH COMPLEX)RAP1RAP2RAP3RHOPH2RHOPH3VAR2CSA (PFEMP1 FAMILY MEMBER)
Complex memberships
RhopH complex (CLAG9-RhopH: RhopH2, RhopH3, RAP1, RAP2, RAP3)

Evidence

Reading pass · 10 per-paper findings extracted from the source corpus
Year Finding Method Journal Conf PMIDs
2000 Targeted gene disruption of CLAG9 in P. falciparum ablated cytoadherence to C32 melanoma cells and purified CD36, establishing CLAG9 as essential for binding of parasitized erythrocytes to CD36. Anti-CLAG9 antibodies recognized a 220 kDa polypeptide absent in disrupted clones. Targeted gene disruption, cytoadherence assay, Western blot with DNA-induced antibodies Proceedings of the National Academy of Sciences of the United States of America High 10737759
2000 Antisense RNA inhibition of CLAG9 in P. falciparum clone 3D7 reduced cytoadherence to C32 melanoma cells 15-fold compared to control, confirming the cytoadherence phenotype is directly caused by loss of CLAG9 function; reversion upon plasmid removal confirmed the effect was not due to an unrelated genomic change. Antisense RNA transfection, cytoadherence assay, plasmid reversion experiment Molecular and biochemical parasitology High 10989143
2004 CLAG9 is a rhoptry protein that localizes specifically to the basal bulb of rhoptries in merozoites (co-localized with RhopH2 by immunofluorescence and immunoelectron microscopy), is a component of the high-molecular-mass RhopH complex (co-purified with anti-RhopH2 antibodies and detected by mass spectrometry), and is transferred to ring-stage parasites within the RhopH complex after invasion. Immunofluorescence, immunoelectron microscopy, mass spectrometry, co-immunoprecipitation/complex purification Molecular microbiology High 15049814
2005 PfRhopH complex immunoprecipitated with anti-CLAG9 antibody contained neither Clag2 nor Clag3.1, indicating that individual PfRhopH complexes contain only one RhopH1/Clag protein product, and CLAG9-containing complexes are compositionally distinct from those containing Clag2 or Clag3.1. Immunoprecipitation with anti-CLAG9 antibody followed by Western blot for Clag2 and Clag3.1 Molecular and biochemical parasitology Medium 15953647
2010 CLAG9 interacts with VAR2CSA (a PfEMP1 family member) at or near the infected red blood cell membrane. In parasites lacking CLAG9, VAR2CSA failed to reach the IRBC surface and was retained within the parasite, demonstrating that CLAG9 is required for trafficking of PfEMP1 to the IRBC surface. CLAG9 is synthesized at two stages (early ring and late trophozoite), and a portion of the protein is exposed on the IRBC surface (trypsin converts ~150 kDa form to ~142 kDa). Co-immunoprecipitation (CLAG9–VAR2CSA interaction), immunofluorescence localization, trypsin sensitivity assay, analysis of CLAG9-knockout parasites Proceedings of the National Academy of Sciences of the United States of America Medium 20823248
2010 Synthetic peptides spanning the complete CLAG9 sequence identified 20 high-affinity erythrocyte-binding peptides (HABPs) that interact with erythrocyte surface receptors of ~85, ~63, and ~34 kDa, and inhibited erythrocyte invasion in vitro by up to 72% at 200 µM. Receptor-ligand binding assay with synthetic peptides, enzyme pre-treatment of RBCs, invasion inhibition assay Vaccine Medium 20085836
2020 PfCLAG9 forms a complex (PfClag9-RhopH complex) with PfRAP1, PfRAP2, PfRAP3, PfRhopH2, and PfRhopH3 at the apical end of merozoites, and the complex binds human erythrocytes through CLAG9 interaction with the glycophorin A–band 3 receptor-coreceptor complex. Immunoprecipitation followed by mass spectrometry, protein-protein interaction assays with recombinant CLAG9 domains, immunofluorescence, erythrocyte binding assay Infection and immunity Medium 31712270
2024 CLAG9 traffics via merozoite rhoptries to the host erythrocyte membrane after invasion and exists in two forms within infected cells: an alkaline-extractable soluble form and a membrane-integral form. Unlike CLAG3, CLAG9 variant region is protease-resistant at the host erythrocyte surface. CLAG9 knockout parasites show uncompromised growth in physiological medium (unlike CLAG3 knockout), and CLAG2 and CLAG8 (but not specifically CLAG9) knockout lines show compensatory increases in transcription of remaining clag/rhoph genes. Epitope-tagging and fluorescence co-localization, alkaline extraction fractionation, extracellular protease treatment, CRISPR/Cas9 knockout, growth assays, PSAC-mediated transport assays Microorganisms High 38930554
2025 In P. berghei, CLAG9 and CLAGX belong to two distinct phylogenetic clades and have separate non-complementary functions: allelic replacement of CLAGX functional regions with P. berghei CLAG9 sequences did not rescue CLAGX function, establishing that P. berghei CLAG9 is not the functional ortholog of P. falciparum CLAG3 and cannot substitute for CLAGX. Allelic replacement in P. berghei, inducible knockout, guanidinium chloride haemolysis assay for NPP function Journal of biomedical science Medium 39894870
2025 PfANK_1, an ankyrin repeat-containing protein, interacts with components of the PfClag9-PfRhopH complex, as shown by co-immunoprecipitation, bio-layer interferometry, and co-localization; structural analysis identified the binding interface and key interacting residues. Co-immunoprecipitation, bio-layer interferometry, co-localization, molecular dynamics simulations, crystal structure of PfANK_1 The FEBS journal Medium 40614121

Source papers

Stage 0 corpus · 14 papers · ranked by NIH iCite citations
Year Title Journal Citations PMID
2000 clag9: A cytoadherence gene in Plasmodium falciparum essential for binding of parasitized erythrocytes to CD36. Proceedings of the National Academy of Sciences of the United States of America 99 10737759
2004 The Plasmodium falciparum clag9 gene encodes a rhoptry protein that is transferred to the host erythrocyte upon invasion. Molecular microbiology 70 15049814
2005 Apical expression of three RhopH1/Clag proteins as components of the Plasmodium falciparum RhopH complex. Molecular and biochemical parasitology 68 15953647
2000 Inhibition of Plasmodium falciparum clag9 gene function by antisense RNA. Molecular and biochemical parasitology 48 10989143
2010 Dual stage synthesis and crucial role of cytoadherence-linked asexual gene 9 in the surface expression of malaria parasite var proteins. Proceedings of the National Academy of Sciences of the United States of America 32 20823248
2013 Cross-reactive anti-PfCLAG9 antibodies in the sera of asymptomatic parasite carriers of Plasmodium vivax. Memorias do Instituto Oswaldo Cruz 11 23440122
2011 Positive selection on the Plasmodium falciparum clag2 gene encoding a component of the erythrocyte-binding rhoptry protein complex. Tropical medicine and health 10 22028613
2020 Plasmodium falciparum Clag9-Associated PfRhopH Complex Is Involved in Merozoite Binding to Human Erythrocytes. Infection and immunity 8 31712270
2010 Sequences of the Plasmodium falciparum cytoadherence-linked asexual protein 9 implicated in malaria parasite invasion to erythrocytes. Vaccine 8 20085836
2012 Stable Allele Frequency Distribution of the Plasmodium falciparum clag Genes Encoding Components of the High Molecular Weight Rhoptry Protein Complex. Tropical medicine and health 7 23264726
2011 Identifying and characterizing a member of the RhopH1/Clag family in Plasmodium vivax. Gene 7 21513780
2024 Plasmodium falciparum CLAG Paralogs All Traffic to the Host Membrane but Knockouts Have Distinct Phenotypes. Microorganisms 4 38930554
2025 Utilisation of an in vivo malaria model to provide functional proof for RhopH1/CLAG essentiality and conserved orthology with P. falciparum. Journal of biomedical science 2 39894870
2025 Deciphering the family of ankyrin repeat-containing proteins of Plasmodium falciparum: a structural and functional perspective. The FEBS journal 0 40614121